Factors influencing treatment decisions in patients with pulmonary arterial hypertension
Hans Klose, Alexander Roitenberg, Kay Kronberg · 2026
Read Factors influencing treatment decisions in patients with pulmonary arterial hypertension by Hans Klose, Alexander Roitenberg, Kay Kronberg (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13638233.txt.
Description
Hans Klose, Alexander Roitenberg, and Kay Kronberg study why doctors treating pulmonary arterial hypertension often start with one drug when guidelines urge combining drugs early. This disease, high blood pressure in the lung arteries, worsens without strong treatment. The team followed seventy-nine patients across centers who started therapy within the past year, recording routine data and asking doctors to explain choices.
Patient risk was the main reason for choosing combined therapy, named in about four fifths of such choices. Other illnesses were the main reason for holding back to one drug. Over two years, the share on combined therapy rose from about forty-six to seventy-eight percent. Patients starting on combined therapy improved their functional class far more often than those starting on one drug. The authors suggest earlier combining could help even patients with other illnesses, a group doctors often treat gently.
Catalog record
| CREATOR | Hans Klose, Alexander Roitenberg, Kay Kronberg |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |